Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients.

ABSTRACT:

Background

The correct management of immunocompromised patients with pneumonia is debated. We evaluated the prevalence, risk factors, and characteristics of immunocompromised patients coming from the community with pneumonia.

Methods

We conducted a secondary analysis of an international, multicenter study enrolling adult patients coming from the community with pneumonia and hospitalized in 222 hospitals in 54 countries worldwide. Risk factors for immunocompromise included AIDS, aplastic anemia, asplenia, hematological cancer, chemotherapy, neutropenia, biological drug use, lung transplantation, chronic steroid use, and solid tumor.

Results

At least 1 risk factor for immunocompromise was recorded in 18% of the 3702 patients enrolled. The prevalences of risk factors sig

SUBMITTER: Di Pasquale MF 

PROVIDER: S-EPMC6481991 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature